Search Within

Paul J Sabbatini

Formats
  1. Journal Article (157)
  2. Meeting Abstract (88)
  3. Book Section (15)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (262)
  2. GDMT, Medicine (262)
  3. Gynecologic Medicine Service (262)
  4. Gynecology Disease Management Team (262)
  5. Solid Tumor Oncology Division (262)
  6. Epidemiology and Biostatistics (82)

More Groups

People
  1. Carol Aghajanian (125)
  2. David Spriggs (81)
  3. Martee Hensley (81)
  4. Jason Konner (52)
  5. William Tew (52)
  6. Alexia Iasonos (44)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Gynecologic Oncology (53)
  3. Clinical Cancer Research (17)
  4. International Journal of Gynecological Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier B.V. (54)
  3. American Association for Cancer Research (23)
  4. Lippincott Williams & Wilkins (19)
  5. Elsevier Inc. (15)
  6. Harborside Press (11)

More Publishers

Results (262)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [Commentary on] Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
    Journal Article

    Sabbatini, P.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • [Commentary on] Clinical evidence for topotecan-paclitaxel non-cross resistance in ovarian cancer
    Journal Article

    Sabbatini, P.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • [Commentary on] Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study
    Journal Article

    Sabbatini, P.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients
    Journal Article

    Hensley, M. L.; Hoppe, B.; Leon, L.; Sabbatini, P.; Aghajanian, C.; Chi, D.; Spriggs, D. R.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Endometrial stromal sarcoma: Objective response to letrozole
    Journal Article

    Maluf, F. C.; Sabbatini, P.; Schwartz, L.; Shia, J.; Aghajanian, C.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer
    Journal Article

    Hensley, M. L.; Lebeau, D.; Leon, L. F.; Venkatraman, E.; Waltzman, R.; Sabbatini, P.; Almadrones, L.; Chi, D.; Spriggs, D.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Complications associated with intraperitoneal chemotherapy catheters
    Journal Article

    Makhija, S.; Leitao, M.; Sabbatini, P.; Bellin, N.; Almadrones, L.; Leon, L.; Spriggs, D. R.; Barakat, R.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Corpus: Epithelial tumors
    Book Section

    Barakat, R. R.; Grigsby, P. W.; Sabbatini, P.; Zaino, R. J.
    In Hoskins, W. J.; Perez, C. A.; Young, R. C. (Eds.) Principles and Practice of Gynecologic Oncology. 3rd ed (2000)

    Fulltext@MSK | Save
  • Phase I trial of a synthetic Lewis(Y) - KLH conjugate vaccine on ovarian cancer patients
    Meeting Abstract

    Sabbatini, P.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S.; Livingston, P.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • A phase I/II trial of intraperitoneal (IP) cisplatin (CDDP) with IP gemcitabine (GEM) in patients (pts) with epithelial ovarian cancer
    Meeting Abstract

    Sabbatini, P.; Aghajanian, C.; Hensley, M.; Tong, W.; Soignet, S.; Hoskins, W.; O'Flaherty, C.; Pezzulli, S.; Barakat, R.; Spriggs, D.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save